Stay updated on T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision v3.3.3 was added to the history. The HHS Vulnerability Disclosure and revision v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-24T14:54:48.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry for v3.3.2 and removes the older v3.2.0 from the visible list. These are administrative updates to the revision list and do not alter the study details or core content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:44:53.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removal of a site-wide government funding/operating status notice from the Record History page; all other content and functionality appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:30:36.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new version on 2025-10-28 updates the recruitment status to Active, not recruiting and adds/updates sections including Contacts/Locations, Study Design, Conditions, Oversight, Study Status, Study Identification, and Recruitment Status.
    Difference
    1%
    Check dated 2025-11-03T21:45:56.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new version entry (Version 21, 2025-01-09) was added to the Record History. It documents an update to the study status and oversight.
    Difference
    0.1%
    Check dated 2025-10-27T21:08:06.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    11%
    Check dated 2025-10-06T08:28:57.000Z thumbnail image

Stay in the know with updates to T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.